The eha research roadmap: normal hematopoiesis

Thierry Jaffredo; Alessandra Balduini; Anna Bigas; Rosa Bernardi; Dominique Bonnet; Bruno Canque; Pierre Charbord; Anna Cumano; Ruud Delwel; Charles Durand; Willem Fibbe; Lesley Forrester; Lucia De Franceschi; Cedric Ghevaert; Bjørn Gjertsen; Berthold Gottgens; Thomas Graf; Olaf Heidenreich; Olivier Hermine; Douglas Higgs; Marina Kleanthous; Hannes Klump; Valerie Kouskoff; Daniela Krause; George Lacaud; Cristina Lo Celso; Joost H.A. Martens; Simón Méndez-Ferrer; Pablo Menendez; Robert Oostendorp; Sjaak Philipsen; Bo Porse; Marc Raaijmakers; Catherine Robin; Henk Stunnenberg; Kim Theilgaard-Mönch; Ivo Touw; William Vainchenker; Joan Lluis Vives Corrons; Laurent Yvernogeau; Jan Jacob Schuringa; Laurent Yvernogeau

doi:10.1097/HS9.0000000000000669

The eha research roadmap: normal hematopoiesis

Thierry Jaffredo^*, Alessandra Balduini, Anna Bigas, Rosa Bernardi, Dominique Bonnet, Bruno Canque, Pierre Charbord, Anna Cumano, Ruud Delwel, Charles Durand, Willem Fibbe, Lesley Forrester, Lucia De Franceschi, Cedric Ghevaert, Bjørn Gjertsen, Berthold Gottgens, Thomas Graf, Olaf Heidenreich, Olivier Hermine, Douglas HiggsMarina Kleanthous, Hannes Klump, Valerie Kouskoff, Daniela Krause, George Lacaud, Cristina Lo Celso, Joost H.A. Martens, Simón Méndez-Ferrer, Pablo Menendez, Robert Oostendorp, Sjaak Philipsen, Bo Porse, Marc Raaijmakers, Catherine Robin, Henk Stunnenberg, Kim Theilgaard-Mönch, Ivo Touw, William Vainchenker, Joan Lluis Vives Corrons, Laurent Yvernogeau, Jan Jacob Schuringa, Laurent Yvernogeau

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

1 Citation (Scopus)

14 Downloads (Pure)

Original language	English
Article number	e669
Journal	HemaSphere
Volume	5
Issue number	12
DOIs	https://doi.org/10.1097/HS9.0000000000000669
Publication status	Published - 30 Dec 2021

Bibliographical note

Funding Information:
WF is a consultant for Glycostem Therapeutics and Starfish Innovations. LF is a consultant for Macomics and Resolution Therapeutics. BG received royalties of payments from Abbvie, Astella, Pfizer, Jazz Pharmaceuticals. OHe received grants from Celgene, BMS, AB science. DK received Research funding from Merck. PM received consultant fees from OneChain Immunotherapeutics. HS received grants from EU HCA|Organoids. KTM was supported by a clinical research fellowship and a center grant from the Novo Nordisk Foundation (grant no. 100191, Novo Nordisk Foundation Center for Stem Cell Biology, DanStem; grant no. NNF17CC0027852, KTM, BP) and by grants from the Danish Council for Strategic Research (grant no. 133100153, KTM), the Danish Cancer Society (grant no. R72-A4572-13-S2, KTM), Børnecancerfonden (2016-0255). WV received patent with a license to Qiagen and research grant from INCYTE. All the other authors have no conflicts of interest to disclose.

Access to Document

10.1097/HS9.0000000000000669Licence: CC BY-NC-ND

The_EHA_Research_Roadmap__Normal_Hematopoiesis.11Final published version, 881 KBLicence: CC BY-NC-ND

Cite this

Jaffredo, T., Balduini, A., Bigas, A., Bernardi, R., Bonnet, D., Canque, B., Charbord, P., Cumano, A., Delwel, R., Durand, C., Fibbe, W., Forrester, L., De Franceschi, L., Ghevaert, C., Gjertsen, B., Gottgens, B., Graf, T., Heidenreich, O., Hermine, O., ... Yvernogeau, L. (2021). The eha research roadmap: normal hematopoiesis. HemaSphere, 5(12), Article e669. https://doi.org/10.1097/HS9.0000000000000669

@article{193f50113a994bc9a5516036b0be73cd,

title = "The eha research roadmap: normal hematopoiesis",

author = "Thierry Jaffredo and Alessandra Balduini and Anna Bigas and Rosa Bernardi and Dominique Bonnet and Bruno Canque and Pierre Charbord and Anna Cumano and Ruud Delwel and Charles Durand and Willem Fibbe and Lesley Forrester and {De Franceschi}, Lucia and Cedric Ghevaert and Bj{\o}rn Gjertsen and Berthold Gottgens and Thomas Graf and Olaf Heidenreich and Olivier Hermine and Douglas Higgs and Marina Kleanthous and Hannes Klump and Valerie Kouskoff and Daniela Krause and George Lacaud and {Lo Celso}, Cristina and Martens, {Joost H.A.} and Sim{\'o}n M{\'e}ndez-Ferrer and Pablo Menendez and Robert Oostendorp and Sjaak Philipsen and Bo Porse and Marc Raaijmakers and Catherine Robin and Henk Stunnenberg and Kim Theilgaard-M{\"o}nch and Ivo Touw and William Vainchenker and Corrons, {Joan Lluis Vives} and Laurent Yvernogeau and Schuringa, {Jan Jacob} and Laurent Yvernogeau",

note = "Funding Information: WF is a consultant for Glycostem Therapeutics and Starfish Innovations. LF is a consultant for Macomics and Resolution Therapeutics. BG received royalties of payments from Abbvie, Astella, Pfizer, Jazz Pharmaceuticals. OHe received grants from Celgene, BMS, AB science. DK received Research funding from Merck. PM received consultant fees from OneChain Immunotherapeutics. HS received grants from EU HCA|Organoids. KTM was supported by a clinical research fellowship and a center grant from the Novo Nordisk Foundation (grant no. 100191, Novo Nordisk Foundation Center for Stem Cell Biology, DanStem; grant no. NNF17CC0027852, KTM, BP) and by grants from the Danish Council for Strategic Research (grant no. 133100153, KTM), the Danish Cancer Society (grant no. R72-A4572-13-S2, KTM), B{\o}rnecancerfonden (2016-0255). WV received patent with a license to Qiagen and research grant from INCYTE. All the other authors have no conflicts of interest to disclose.",

year = "2021",

month = dec,

day = "30",

doi = "10.1097/HS9.0000000000000669",

language = "English",

volume = "5",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wolters Kluwer Health",

number = "12",

}

Jaffredo, T, Balduini, A, Bigas, A, Bernardi, R, Bonnet, D, Canque, B, Charbord, P, Cumano, A, Delwel, R, Durand, C, Fibbe, W, Forrester, L, De Franceschi, L, Ghevaert, C, Gjertsen, B, Gottgens, B, Graf, T, Heidenreich, O, Hermine, O, Higgs, D, Kleanthous, M, Klump, H, Kouskoff, V, Krause, D, Lacaud, G, Lo Celso, C, Martens, JHA, Méndez-Ferrer, S, Menendez, P, Oostendorp, R, Philipsen, S, Porse, B, Raaijmakers, M, Robin, C, Stunnenberg, H, Theilgaard-Mönch, K, Touw, I, Vainchenker, W, Corrons, JLV, Yvernogeau, L, Schuringa, JJ & Yvernogeau, L 2021, 'The eha research roadmap: normal hematopoiesis', HemaSphere, vol. 5, no. 12, e669. https://doi.org/10.1097/HS9.0000000000000669

TY - JOUR

T1 - The eha research roadmap

T2 - normal hematopoiesis

AU - Jaffredo, Thierry

AU - Balduini, Alessandra

AU - Bigas, Anna

AU - Bernardi, Rosa

AU - Bonnet, Dominique

AU - Canque, Bruno

AU - Charbord, Pierre

AU - Cumano, Anna

AU - Delwel, Ruud

AU - Durand, Charles

AU - Fibbe, Willem

AU - Forrester, Lesley

AU - De Franceschi, Lucia

AU - Ghevaert, Cedric

AU - Gjertsen, Bjørn

AU - Gottgens, Berthold

AU - Graf, Thomas

AU - Heidenreich, Olaf

AU - Hermine, Olivier

AU - Higgs, Douglas

AU - Kleanthous, Marina

AU - Klump, Hannes

AU - Kouskoff, Valerie

AU - Krause, Daniela

AU - Lacaud, George

AU - Lo Celso, Cristina

AU - Martens, Joost H.A.

AU - Méndez-Ferrer, Simón

AU - Menendez, Pablo

AU - Oostendorp, Robert

AU - Philipsen, Sjaak

AU - Porse, Bo

AU - Raaijmakers, Marc

AU - Robin, Catherine

AU - Stunnenberg, Henk

AU - Theilgaard-Mönch, Kim

AU - Touw, Ivo

AU - Vainchenker, William

AU - Corrons, Joan Lluis Vives

AU - Yvernogeau, Laurent

AU - Schuringa, Jan Jacob

AU - Yvernogeau, Laurent

N1 - Funding Information: WF is a consultant for Glycostem Therapeutics and Starfish Innovations. LF is a consultant for Macomics and Resolution Therapeutics. BG received royalties of payments from Abbvie, Astella, Pfizer, Jazz Pharmaceuticals. OHe received grants from Celgene, BMS, AB science. DK received Research funding from Merck. PM received consultant fees from OneChain Immunotherapeutics. HS received grants from EU HCA|Organoids. KTM was supported by a clinical research fellowship and a center grant from the Novo Nordisk Foundation (grant no. 100191, Novo Nordisk Foundation Center for Stem Cell Biology, DanStem; grant no. NNF17CC0027852, KTM, BP) and by grants from the Danish Council for Strategic Research (grant no. 133100153, KTM), the Danish Cancer Society (grant no. R72-A4572-13-S2, KTM), Børnecancerfonden (2016-0255). WV received patent with a license to Qiagen and research grant from INCYTE. All the other authors have no conflicts of interest to disclose.

PY - 2021/12/30

Y1 - 2021/12/30

UR - http://www.scopus.com/inward/record.url?scp=85120666780&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000669

DO - 10.1097/HS9.0000000000000669

M3 - Review article

C2 - 34853826

AN - SCOPUS:85120666780

SN - 2572-9241

VL - 5

JO - HemaSphere

JF - HemaSphere

IS - 12

M1 - e669

ER -

The eha research roadmap: normal hematopoiesis

Bibliographical note

Access to Document

Other files and links

Cite this